Cresco Labs (CRLBF) Return on Capital Employed (2021 - 2026)
Cresco Labs' (CRLBF) quarterly Return on Capital Employed came in at 2.76% in Q1 2026, down 1012.0% YoY from 0.3% in Q1 2025, and down 12.46% on a QoQ basis from 2.46% in Q4 2025.
Cresco Labs (CRLBF) Return on Capital Employed (2021 - 2026) Analysis & Trends
Cresco Labs (CRLBF) has 6 years of Return on Capital Employed data on file, last reported at 2.76% in Q1 2026.
- Quarterly Return on Capital Employed fell 1012.0% year-over-year to 2.76% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 2.76% (down 1012.0% YoY) and the FY2025 annual result came in at 2.38%, down 1088.0% from the prior year.
- Return on Capital Employed retreated to 2.76% in Q1 2026, from 2.46% in the prior quarter.
- In the past five years, Return on Capital Employed ranged from a high of 9.49% in Q3 2024 to a low of 21.64% in Q3 2023.
- A 5-year average of 2.62% and a median of 2.76% in 2026 frame the typical range for Return on Capital Employed.
- Annual changes were most pronounced in 2023 — Return on Capital Employed plunged 2676 bps — and 2024, when it jumped 3112 bps.
- Tracing CRLBF's Return on Capital Employed over 5 years: stood at 5.96% in 2022, then decreased by 25 bps to 7.45% in 2023, then soared by 213 bps to 8.42% in 2024, then plunged by 129 bps to 2.46% in 2025, then fell by 12 bps to 2.76% in 2026.
- The last three Return on Capital Employed figures came in at 2.76% (Q1 2026), 2.46% (Q4 2025), and 5.5% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | 6.60% |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | 17.16% |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 6.07% |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 22.04% |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | -0.29% |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 18.67% |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 5.52% |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Cresco Labs | 304.06 Mn | 239.95 Mn | 86.95 Mn | -3.03% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.76% |
| Dec 31, 2025 | -2.46% |
| Sep 30, 2025 | 5.50% |
| Jun 30, 2025 | 6.02% |
| Mar 31, 2025 | 7.36% |
| Dec 31, 2024 | 8.42% |
| Sep 30, 2024 | 9.49% |
| Jun 30, 2024 | -1.56% |
| Mar 31, 2024 | -5.41% |
| Dec 31, 2023 | -7.45% |
| Sep 30, 2023 | -21.64% |
| Jun 30, 2023 | -10.39% |
| Mar 31, 2023 | -7.80% |
| Dec 31, 2022 | -5.96% |
| Sep 30, 2022 | 5.13% |
| Jun 30, 2022 | -9.98% |
| Mar 31, 2022 | -10.96% |
| Dec 31, 2021 | -11.76% |